Board of Directors

Douglas L. Drysdale
Chairman, President and Chief Executive Officer
Mr. Drysdale served as Chief Executive Officer of Alvogen, Inc., from 2008 to 2013, building the company from inception to become a global leader in pharmaceuticals. Alvogen now operates in thirty countries and has a portfolio of over 200 projects in development and registration. Prior to Alvogen, Mr. Drysdale helped build the multinational pharmaceutical giant Actavis, as head of mergers and acquisitions and a member of the executive board, spearheading specialty acquisitions…
[Read More]

Steven A. Elms
Steven A. Elms became an independent director, under the rules of the NYSE Amex, on the Company’s Board of Directors on August 31, 2011. Mr. Elms also serves as chairman of the Audit Committee and serves as a member of the Nominating and Compensation committees. Mr. Elms is also the Audit Committee’s “financial expert.” Mr…
[Read More]

John Sedor
John Sedor is a non-executive independent Director and currently serves as Chairman of the Compensation Committee. Mr. Sedor also serves on the Audit Committee and the Nominating Committee of the Board. Prior to his current role as President and CEO at Rodes Inc., Mr. Sedor most recently served as…
[Read More]

Tasos Konidaris
Tasos Konidaris is a non-executive independent Director and currently serves as Chairman of the Audit Committee. Mr. Konidaris also serves on the Compensation Committee and the Nominating Committee of the Board. Mr. Konidaris has served as Senior Vice President and Chief Financial Officer of Ikaria, Inc., a biotherapeutics company, since October 2011. Prior to joining Ikaria…
[Read More]